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Abstract 
Inflammation is signaled by the overexpression of epitopes on the vascular endothelium that 
primarily aim at recruiting immune cells into the inflamed area. The intravascular localization of 
these biomarkers makes them suitable targets for the MRI visualization of inflammation. 
Phospholipid-based nanosystems appear excellent candidates in virtue of their good 
biocompatibility, ability to deliver a high number of imaging units at the target site, and for the easy 
functionalization with targeting vectors. In this work, phospholipid-based micelles (hydrodynamic 
diameter of 20 nm) loaded with the amphiphilic Gd(III)-complex Gd-DOTAMA(C18)2 were 
vectorized with a small peptide able to specifically bind VCAM-1 receptors. The micelles displayed 
a high longitudinal relaxivity (36.4 s-1mmolGd
-1 at 25°C and 0.7 T). A 1H- and 17O-water 
relaxometry study indicated that the paramagnetic complex embedded in the nanoparticles adopted 
two isomeric conformations, likely reflecting the well known square antiprismatic (SAP) and 
twisted square antiprismatic (TSAP) configurations typically observed in DOTA-like lanthanide 
complexes. Interestingly, the TSAP structure, showing a much faster exchange rate for the water 
molecule coordinated to the metal ion, was the most abundant, thus explaining the high relaxivity of 
the micellar agent.  
The systemic administration of the micelles into a LPS-induced murine model of acute 
inflammation successfully demonstrated the ability of the targeting agents to detect the diseased 
area by T1 contrast enhanced MRI. 
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Introduction 
Inflammation is a complex phenomenon that implies a series of molecular and cellular 
modifications, such as changes in the vascular permeability and volume, infiltration and activation 
of both circulating leukocytes and resident immune competent cells.1 Although the inflammatory 
response varies considerably with the nature of the insult, it occurs in many pathologies including 
atherosclerosis, cancer and diseases of the nervous system.2-4 The activation of inflammatory cells 
in response to an injury is accompanied by the upregulation of endothelial inflammatory proteins, 
such as endothelial cell adhesion molecules (CAMs). These molecules (e.g. VCAM-1, ICAM-1, 
PECAM, E- and P-selectins) play an important role in the tethering, rolling, adhesion, and 
extravasation of immune cells, in particular leucocytes.5,6 The molecular mechanisms responsible 
for specific recognition steps between activated cells and endothelium represent an intriguing 
opportunity for the design of imaging agents able to visualize the inflammation process. 
Furthermore, the intravascular localization of these epitopes makes them easily accessible for a 
systemically injected agent, and this feature is particularly important when signal amplification 
strategy is necessary to detect the target-associated imaging response. 
Among CAMs, Vascular Cell Adhesion Molecule-1 (VCAM-1, member of the Ig superfamily) has 
been shown to be an important biomarker of several inflammatory disorders, mediating leukocyte 
movement across the endothelium, and its overexpression is recognized as a typical endothelial 
marker of inflammation,7-9 though it has been demonstrated to be involved also in other biological 
events.10 Most of the clinically available imaging techniques, namely Positron Emission 
Tomography (PET), Computed Tomography (CT), Ultrasound (US), and Magnetic Resonance 
Imaging (MRI) are currently under intense scrutiny for the design of protocols aimed at visualizing 
the inflammatory response.11 In virtue of the use of non-ionizing radiations, as well as of the superb 
spatial resolution and ability to differentiate soft tissues, MRI is an excellent candidate to tackle this 
task. Moreover, MRI is often considered the technique of choice in the diagnosis of diseases with 
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strong inflammatory components, such as stroke and atherosclerosis.12-14 Due to the poor sensitivity 
in the detection of molecular MRI agents, the search for signal amplification strategies is mandatory 
for the design of MR-molecular imaging protocols.15 Typically, the increase in sensitivity is 
achieved by loading a high number of imaging probes (e.g. Gd-complexes) on macromolecular or 
nano/microsized carriers. These systems (especially nano/microparticles) have a limited or null 
blood extravasation, thus making them optimal candidates for the detection of intravascular targets.  
Much efforts for the MRI visualization of inflammation have dealt with the use of agents reporting 
about the recruitment of immune cells in the diseased region.16,17 Nevertheless, MR-molecular 
imaging of inflammation using contrast agents directed to vascular inflammatory markers is an 
expanding field of research and several successful examples have been already reported.18  
In particular, VCAM-1 receptors have been exploited as MR-molecular target in experimental 
models of cardiovascular and neurologic diseases, and in some cases, superparamagnetic iron 
oxides particles were used as imaging reporting units.19-22  
Though quite sensitive, such particles generate a T2
*/T2 contrast that leads to a loss of MRI signal, 
thus making difficult their detection in tissues with intrinsically low signal. 
In this respect, contrast agents that yield a T1 weighted signal enhancement, as Gd- or Mn-based 
probes, appear preferable. So far, two examples of Gd-based T1 agents targeting VCAM-1 receptors 
can be found in literature. In one case, a monomeric Gd-DOTA-like complex (DOTA:1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid) was conjugated to a peptide selected by phage 
display showing high affinity to the target.23 Quite unexpectedly, the presence of a single Gd per 
targeting vector (relaxivity of ca. 7.0 s-1mMGd
-1 at 1.5 T and 37°C) allowed for the detection of 
inflamed states in mice models of hepatitis (MRI contrast enhanced by a factor of 3 with respect to 
the untargeted agent) and atherosclerosis (enhancement of a factor < 2 in comparison with the agent 
conjugated with a scrambled untargeted peptide) in mice models. 
The second study dealt with rod-like nanoparticles of tobacco mosaic virus that were covalently 
conjugated to a VCAM-1 peptide and loaded with ca. 1200 units of a Gd-DOTA-like complex 
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(relaxivity of 14.6 s-1mMGd
-1 at 1.5 T and 25°C).24 Injected in a mouse model of atherosclerosis, this 
agent produced a two/threefold increase in MRI contrast when compared with both healthy mice 
and diseased animals administered with free Gd-DOTA.  
With the aim to further improve the MRI detectability of VCAM-1 receptors using Gd-based 
agents, we report here a new nanosized agent based on mixed micelles made of a pegylated 
phospholipid, an amphiphilic Gd-complex, and a newly-synthesized phospholipid conjugated to the 
VCAM-1 targeting peptide (DSPE-PEG2000-peptide in Scheme 1).  
We tested the in vivo MRI performance of the paramagnetic micelles on a LPS (lipopolysaccharide) 
-induced peripheral inflammation model in mice.25 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Micelles composition: DSPE-PEG2000-OMe (white circle), DSPE-PEG2000-peptide (green circle), Gd(III)-
DOTAMA(C18)2 (red circle)  
 
Results  
Synthesis and characterization of DSPE-PEG2000-peptides 
The VCAM-1 receptor targeting cyclic nonapeptide C*NNSKSHTC* and its untargeted scrambled 
version HSC*NKNSC*T were synthetized by Solid Phase Peptide Synthesis. The first aminoacids 
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(C and T, respectively) were attached to the resin manually, whereas the remaining amino acids 
were sequentially and automatically conjugated afterwards. The so-obtained linear nonapeptides 
were cleaved from the resin using a solution of TFA (trifluoroacetic acid) /TIPS(triisopropylsilane) 
/EDT (ethanedithiol) and then cyclized to obtain the final products (yield ca. 60%). Next, the 
peptides were reacted with DSG to conjugate the mono- N-hydroxy succinimide (NHS) ester at the 
amino group of the Lys residue of the cyclic peptides (Scheme 2). The activated NHS moiety 
allowed for the conjugation of DSPE-PEG2000-NH2 to form DSPE-PEG2000-VCAM1-pep and 
DSPE-PEG2000-scr-pep with a yield of about 50 %.26 The formation of the products was monitored 
by analytical HPLC, whereas purification was carried out by preparative HPLC using a buffered 
solution of ammonium acetate as eluent. The characterization of the final products was performed 
by 1H-NMR and Mass spectrometry (see Supplementary material). A purity around 70 % was 
determined by analytical HPLC-ELSD for both the compounds. The remaining 30% was 
represented by the unconjugated phospholipid DSPE-PEG2000-NH2 . Due to the small amount of 
targeting phospholipid used in the formulation, it can be assumed that the unconjugated 
phospholipid (whose amount was anyhow considered in the formulation of the micelles) did not 
interfere with the micelle formation. 
 
Preparation and characterization of the mixed micelles 
Paramagnetic mixed micelles were prepared by blending DSPE-PEG2000-OMe, DSPE-PEG2000-
VCAM1-pep (or DSPE-PEG2000-scr-pep), and Gd-DOTAMA(C18)2 in the molar ratio of 58:2:40, 
respectively. The hydrodynamic diameter of the micelles (determined by DLS on 3 batches) was 20 
nm with a PDI of 0.2 ± 0.1. The millimolar longitudinal relaxivity (r1) at 0.5 T of the micelles 
exposing the targeting peptide was 34.9 s-1mmolGd
-1 at 25°C and 35.3 s-1mmolGd
-1 at 37°C. The 
relaxivity was also measured as a function of the proton Larmor frequencies (from 0.01 to 70 MHz) 
and the experimental data are reported in Figure 1 (left).  
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Scheme 2. Synthetic pathway to DSPE-PEG2000-VCAM1-pep. (a) DSG, DIPEA, DMF, 2 min; (b) DSPE-PEG2000-
NH2, DIPEA, DMSO, 24 h. 
 
The obtained NMRD (Nuclear Magnetic Relaxation Dispersion) profile is characterized by a 
relaxivity hump at ca. 20-30 MHz, a feature that clearly indicates the occurrence of a restricted 
rotational motion for the paramagnetic Gd-complexes in the micelles.27 
The NMRD data were complemented by the measurement of the temperature dependence of the 
transverse relaxation of 17O-water, from which it is possible to determine the exchange lifetime, τM, 
of the water molecule coordinated to the metal centre.  
Very interestingly, the data displayed a ”two-components” behaviour, thus indicating the presence 
of two species with very different exchange dynamics of their Gd-bound waters (Figure 1, 
right).28,29 Since several parameters controlling 1H and 17O relaxation rates are common, NMRD 
and 17O-data were analysed simultaneously according to the well-established Solomon-
Bloembergen-Morgan and Freed theories.27 
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Figure 1. NMRD profile at 25°C(left) and temperature dependence of water 17O-R2p (right, normalized to 20 mM of Gd) 
of VCAM-1 targeted paramagnetic micelles.  
 
 
As such theories have some limitations to properly model the behaviour of slowly tumbling systems 
at low Larmor frequencies,30 NMRD data were analysed only in the high-frequency region (> 5 
MHz). 
The results from the fitting of experimental vs calculated values are reported in Table 1, whereas 
Figure 2 shows the fitting curves as well as the relative contributions of the two species to the 
measured relaxation rates. 
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Figure 2. NMRD (left) and 17O-data (right) analyzed according to the SBM-Freed theory for a system containing two 
species. Red and blue lines represent the contribution from species 1 and 2, respectively.  
 
The analysis was carried out by considering ∆2, τV, τR, τM, and the molar fraction of the two species 
(assumed to be temperature independent) as variable parameters, whereas all the other parameters 
were fixed to the values reported in the footnote of Table 1. As it has been reported that the 
hydration state (expressed by the q/r6 value) of Gd(III) in macrocyclic conformers with different 
water exchange rates is inversely related to the τM value,
31,32 the analysis was performed using rGd-H 
values of 3.0 Å and 3.1 Å for species 1 and 2, respectively.31  
The good quality of the data fitting is an indirect proof that the advantages deriving from a fast 
water exchange rate are partially limited by a reduced hydration state. 
 
 
Table 1. Values of the parameters obtained from the simultaneous fitting of NMRD and 17O-R2p data for the VCAM-1 
targeted paramagnetic micelles. The values of τV, τR, and τR refer to 25°C. 
 
 
 
 
 
 
 
The following parameters were kept fixed during the fitting procedure: rGd–H = 3.0 Å (SAP), 3.1 Å (TSAP); rGd–O = 2.5 
Å, D = 2.25×10-5 cm2s-1, q = 1, a = 3.8 Å, A/h = -3.8×106. The activation energies related to the dynamic parameters 
obtained from the analysis were: EτV = 7.8 kJ/mol, EτR = 13.1 kJ/mol, EτM = 27.2 kJ/mol (SAP); EτV = 0.9 kJ/mol, EτR = 
10.7 kJ/mol, EτM = 53.7 kJ/mol (TSAP). 
 
Parameter Species 1 (SAP) Species 2 (TSAP) 
∆2 ×1019(s-2) 2.2 ± 0.9  0.9 ± 0.1 
τV (ps) 58.7 ± 4.9 41.4 ± 11.9 
τM (ns) 380.1 ± 21.4 1.5 ± 0.2 
τR (ns) 7.9 ± 0.8 7.5 ± 0.7 
Mol. Fraction (%) 21.1 78.9 
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The result of the analysis is consistent with the presence of two paramagnetic species with a 
predominance of the complex with a very short water exchange lifetime (species 2). The occurrence 
of a very short τM may considerably reduce the contribution of the complex to the water 
17O-R2p 
values as the temperature increases. Conversely, the contribution from the complex with the slower 
water exchange rate (species 1) displayed a monotonic increase of 17O-R2p values with temperature. 
Therefore, in spite of the higher amount of the species 2 in the solution, 17O-R2p relaxation is almost 
exclusively determined by species 1 at physiological temperature. 
On the other hand, the effect of τM on the proton relaxivity is quite different, and the r1 values of the 
micellar agent are mainly determined by the contribution of the species 2 over the entire interval of 
magnetic field strengths investigated. 
The in vitro stability of the micelles was assessed at 37°C in human serum, by measuring both size 
and proton relaxation rate as function of time (Figure S5). The stability of the nanoparticles was 
excellent and no changes in size and R1 values were observed over a period of 5 days.  
 
In vivo MRI testing of the paramagnetic micelles  
The in vivo MRI performance of the micelles was tested on a murine inflammation model obtained 
by injecting LPS in the mouse leg skeletal muscles. Conventional H&E (hematoxylin and eosin) 
histology confirmed the extensive infiltration of monocytes, lymphocytes and neutrophils in the leg 
48 h after LPS injection (Figure 3). Furthermore, immunofluorescence experiments confirmed the 
expression of VCAM-1 receptors in the inflamed muscle (Figure S6). 
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Figure 3. Histological slices stained with hematoxilin-eosin of inflamed (left) and healthy (right) leg skeletal muscle. 
 
48 h after the induction of inflammation, the paramagnetic micelles (containing the targeting or the 
scrambled peptide) were injected intravenously in the tail vein at a Gd dose of 55.0 µmol/kg bw. 
Then, the animals (n = 6) were scanned by MRI (at 1 T) over a period of 24 h post injection. A T1 
contrast enhancement around 45 % was observed in the inflamed region 4 h post injection (Figure 
4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. MRI T1 contrast enhancement at 1 T measured after intravenous injection of paramagnetic micelles. Blu bars 
refer to the VCAM-1 targeted micelles on inflamed leg while red bars to the control experiment (scrambled peptide) on 
inflamed leg. Cyan and yellow bars refer to targeted and control micelles on healthy leg, respectively (*** p < 0.01 -   
** p < 0.05). Error bars represent SE (Standard Error) on mean (n = 6).  
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The contrast measured in the inflamed leg was ca. fivefold higher than the enhancement detected in 
the contralateral healthy leg, and twofold higher than the response measured upon administration of 
the control micelles functionalized with the scrambled peptide. The MR images reported in Figure 5 
show that 4 h after the injection of the micelles, an hyperintense signal was visible in the inflamed 
leg (red circle), while no brightening was detected in the control experiment. 
 
 
 
 
 
 
 
 
Figure 5. Axial T1w MR images of the legs of C57BL/6J mice acquired pre (A, E) , 40 min (B, F), 4 h(C, G) and 24 h 
(D, H) after the injection of micelles targeting VCAM-1 receptors (top row) or micelles loaded with the scrambled 
peptide (bottom row). LPS was injected in the right leg muscle. The red oval highlights the inflamed area detected with 
the targeted agent.  
 
Besides the inflamed legs, a significant MRI contrast was also detected in liver, spleen and kidneys 
even 24 hours after the injection of the micelles (Figure S7).  
The accumulation of the MRI agent in the legs was confirmed by ICP-MS analysis (Figure 6), 
which showed that the amount of metal ion in the inflamed muscles after the injection of the 
VCAM-1-targeted micelles was ca. 40 % higher than the amount found in the diseased tissue after 
the injection of the control micelles loaded with the scrambled peptide, and ca. threefold higher 
with respect to the Gd found in the healthy muscles regardless of the type of micelles injected.  
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Figure 6. Amount of Gd (normalized to the organ weight) measured in legs excised 4 h after the intravenous injection of 
paramagnetic micelles. Red: VCAM-1 targeted agent, Green: control agent. Error bars refer to the SE on mean (n = 6). 
 
 
Discussion  
The primary motivation of this work was to develop an improved MRI T1 Gd-based agent for 
targeting the intravascular VCAM-1 receptors, as biomarker of endothelium activated by 
inflammation.  
The most straightforward approach to increase the detection sensitivity of MRI contrast is to load a 
high number of paramagnetic centers to a nanocarrier suitably designed to bind the desired target. 
The loading of the agent to the carrier invariably slows down the rotational motion of the 
paramagnetic complex, and, consequently, it can markedly affect the magnetic field dependence of 
the relaxivity of the system. In particular, an increase in sensitivity occurs in a field range between 
0.2 and 1.5 T, mainly depending on the exchange rate of the Gd-bound water protons, and the 
electronic relaxation times of the paramagnetic center. 
Though several hints to design Gd(III) complexes with high relaxivity at fields exceeding 1.5 T 
have been already proposed,33,34 the simplest approach to increase the sensitivity relies on: a) the 
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use of thermodynamically and kinetically stable Gd-agents (possibly already validated in vivo), b) 
their loading into a biocompatible targeted carrier, and c) the detection of the contrast on a MR 
scanner operating at a magnetic field chosen to maximize the relaxometric properties of the agent. 
Steps a and b are somehow related because the choice of the Gd-agent may be influenced by the 
physico-chemical properties of the carrier. In this work, we decided to use phospholipid-based 
micelles for their high biocompatibility and favorable pharmacokinetic properties. The easiest way 
to load a MRI agent in these soft self-aggregates is through the design of a metal complex with a 
phospholipid-like structure, i.e. characterized by the presence of a lipophilic portion conjugated to 
the hydrophilic coordination cage hosting the paramagnetic metal. 
The complex Gd-DOTAMA(C18)2 perfectly meets this requirement, and it was already successfully 
used in many literature reports, mostly incorporated in bilayered membranes of liposomes.35-37 
Though the presence of an amidic coordinating group does not guarantee an optimal exchange rate 
of the water molecule bound to the metal, the thermodynamic and kinetic stabilities of the complex, 
as well as the efficiency and stability of the loading to lipid-based particles, are very good, thus 
making this agent an excellent option for the preparation of MRI detectable nanocarriers.  
In addition to the MRI probe, micelles were also loaded with a newly synthesized phospholipid-
based peptide for targeting VCAM-1 receptors. The peptide, selected by phage display by others,23 
was prepared by solid phase synthesis and then conjugated at the polar distal end of the 
phospholipid DSPE-PEG2000. In parallel, a non-targeted scrambled version of the peptide was 
synthesized, conjugated with the same phospholipid, and used to prepare paramagnetic micelles 
acting as control for the in vivo imaging experiments.  
The shape of the NMRD profile measured for the paramagnetic micelles (Figure 1, left) was fully 
consistent with the occurrence of a restricted rotational motion for the Gd-complex embedded in the 
nanoparticle. The relaxivity reached a maximum value of 36.4 s-1mMGd
-1 at the Larmor frequency 
of 30 MHz (and 25°C), i.e. about fivefold larger than the corresponding value measured for the 
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monomeric agent reported in ref. 23, and 2.5 times higher than the r1 value reported for nanosized 
agent based on the tobacco mosaic virus.24 
In the latter system, a number of ca. 1200 Gd-complexes per particle was estimated, which led to a 
particle relaxivity of 17520 s-1mM-1. We made a rough calculation of the number of Gd-
DOTAMA(C18)2 units loaded into a single micelle on the basis of the area occupied by the two 
main components (DSPE-PEG2000 and Gd-DOTAMA(C18)2, see Experimental Procedures). 
Considering a molecular surface area of 0.45 nm2 and 0.8 nm2 for DSPE-PEG2000 and Gd-
DOTAMA(C18)2, respectively,
36,38 and using the average particle radius obtained by DLS 
measurements (10 nm), ca. 850 Gd-complexes resulted to be loaded in a single micelle, which 
corresponds to a particle relaxivity of about 30000 s-1mM-1, with an improvement of ca. 70 % with 
respect to the agent reported in ref. 24.  
Interestingly, the temperature dependence of water 17O-R2p (Figure 1, right) clearly indicated the 
presence of two paramagnetic species in the micelles suspension, characterized by very different 
water exchange rates. 
This behavior, which was observed in a series of trans-bisamide derivatives of Gd-DOTA28 and 
more recently even for Gd-HPDO3A,29 can be interpreted in terms of the presence of comparable 
amounts of the two conformational isomers of Ln-DOTA complexes with capped square 
antiprismatic (SAP) and capped twisted square antiprismatic (TSAP) structure.39  
It has been clearly demonstrated that the two isomeric configurations display different exchange 
rates for the water molecule occupying the capped position, being the TSAP isomer the structure 
with the faster exchange.40,41  
The simultaneous analysis of NMRD and 17O-R2p data for the paramagnetic micelles investigated in 
this work allowed the estimation of the residence lifetime (τM) for the Gd-bound water molecule in 
the two species that resulted to be 380 ns and 1.5 ns for SAP and TSAP isomers, respectively 
(Table 1). Therefore, it is straightforward to assign the species with the larger τM value to the SAP 
conformation and that one with the faster exchange to the TSAP structure. The ratio between the τM 
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values for the two diastereoisomers (about 310) lies in the middle of the range reported in literature 
for Gd-DOTA bisamide complexes (100-700).28 However, likely due to the electroneutrality of Gd-
DOTAMA(C18)2 complex, the exchange lifetime for both the isomers incorporated in the micelles is 
almost an order of magnitude lower than the mono-positively charged bisamide derivatives.  
Due to the water insolubility of Gd-DOTAMA(C18)2, it was not possible to assess if the distribution 
(21.8% SAP and 78.2 % TSAP as obtained from the relaxometric analysis) and water dynamics of 
two isomers are influenced by the inclusion of the amphiphilic complex in the nanoparticle. 
Actually, effects of the characteristics of the local microenvironment on the isomer distribution in 
DOTA-amide complexes have been already reported.42 It is interesting to note that, unlike other 
macrocyclic complexes, the SAP/TSAP ratio for Gd-DOTAMA(C18)2 in micelles is lower than 1. 
This finding is very important because the occurrence of a short water residence lifetime allows the 
attainment of high relaxivities especially when (as in this case) the Gd-complex experiences a slow 
rotational motion.  
The different water exchange regime for the two conformations likely accounts for the very similar 
r1 values (at 0.5 T) measured at 25°C (34.9 mM
-1s-1) and 37 °C (35.3 s-1mM-1), respectively.  
The NMRD profile clearly identifies the range of magnetic field where the micelles display the best 
performance to generate MRI contrast and, on this basis, the in vivo testing was performed at 1 T 
(corresponding to a Larmor frequency of 42.5 MHz).  
The agent was validated in vivo on an inflammation model obtained upon intramuscular injection of 
LPS in mice leg. The effective onset of inflammation 48 hours after LPS injection was confirmed 
histologically (Figure 3). 
The paramagnetic micelles were intravenously injected at a dose of 55.0 µmol Gd/kg bw, and the 
animals were monitored by MRI at different times (20 min, 40 min, 4 h, 4.5 h, and 24 h) post 
injection. The data shown in Figure 4 indicated that the micelles targeting VCAM-1 receptors 
yielded a maximum contrast enhancement (ca. 45 %) 4 h post-injection. Such a contrast was ca. 
fivefold higher than the response observed in the healthy contralateral leg, and ca. twofold higher 
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than the contrast measured upon injection of the control micelles loaded with the scrambled peptide. 
Likely, the difference in the contrast observed between the diseased and the healthy leg after the 
injection of the control micelles (also observed in ref. 23) can be ascribed to a non-specific 
accumulation of the untargeted probe in the lesion.  
The different contrast enhancement measured in vivo was confirmed by the amount of Gd 
determined in the explanted muscles by ICP-MS. The data obtained (shown in Fig. 6) paralleled the 
trend observed for the MRI contrast, thus highlighting the superior accumulation of the targeted 
agent in the inflamed region. However, the difference observed among the experimental groups in 
the ICP-MS analysis was smaller than MRI contrast (e.g. the 40 % difference between the amount 
of Gd found in the inflamed muscles in targeted and control groups was not statistically significant). 
This is likely the result of the different contribution of the inflamed tissues in the two experiments. 
In fact, while it was possible to calculate the MRI contrast mostly in the inflamed area, the amount 
of Gd was determined over the whole explanted muscle, thus diluting the difference with the control 
group.  
In conclusion, this work proposes a new highly sensitive MRI nanoagent for the in vivo 
visualization of inflammation through the targeting of the intravascular VCAM-1 receptors. The 
system derives by the self-assembling of natural phospholipids (or partly conjugated with a VCAM-
1 directed peptide) and an amphiphilic Gd-complex, which forms micelles with a diameter of ca. 20 
nm. The combination between the high relaxivity displayed by the single contrastophore and the 
high number of complexes loaded per micelle makes this agent suitable to overcome the sensitivity 
issue often associated with MR-molecular imaging experiments. However, the favorable property of 
this agent can be fully exploited only if it is imaged at a magnetic field tuned with the NMRD 
profile of the system (here 0.5-1.5 T). When injected in vivo in a mouse model of acute 
inflammation and monitored at 1 T, the agent performed very well allowing the detection of a 
contrast about fivefold higher than that one measured in the non inflamed tissue. 
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We expect that the herein reported results will stimulate researches to further assess and optimize 
the pharmacokinetic properties with the ultimate goal to develop a clinical-translatable MRI agent 
for diagnostic/theranostic protocols on inflammation-associated diseases. 
 
 
Experimental Procedures 
Chemicals 
1,2- distearoyl-sn-glycero-3-phospho-ethanolamine-N-[amino(poly-(ethylene glycol)2000] 
ammonium salt (DSPE-PEG2000-NH2), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N- 
[methoxy(polyethylene glycol)-2000] ammonium salt (DSPE-PEG2000-OMe)were obtained from 
Avanti Polar Lipids (Alabaster,USA). Gd-DOTAMA(C18)2 was synthesized as described 
elsewhere.43 Disuccinimidyl glutarate (DSG) was prepared in-house from glutaric acid and NHS.  
 
Synthesis of the targeting peptide and its scrambled version 
The peptides C*NNSKSHTC* and HSC*NKNSC*T were synthesized on Liberty CEM microwave 
peptide synthesizer using H-Cys(Trt)-2-chlorotrityl resin and standard FMOC 
(fluorenylmethyloxycarbonyl chloride) chemistry.  
The attachment of the first amino acid Fmoc-Cys-(Trt)-OH or Fmoc-Tyr(tBu)-OH to 2-chlorotrityl 
chloride resin to give H-Cys(Trt)-2-chlorotrityl resin was carried out as follows: 
Fmoc-Cys-(Trt)-OH (3.28 g, 5.6 mmol) or Fmoc-Tyr(tBu)-OH (2.76 g, 6 mmol) was dissolved in 5 
ml of DCM (dichloromethane) and then added with DIPEA (diisopropylethylamine) (0.896 ml, 5.12 
mmol). The mixture was stirred for 10 minutes. While under stirring, 2-Chlorotrityl chloride resin 
(2.0 g, 2.24 mmol,) was added. The resulting mixture was continuously stirred for 3 hours. The 
resin was filtered and washed with DCM (10 ml×6 washings 3 min each). The resin was capped 
with MeOH (methanol):DIPEA (5:1, 10 ml×3 times) for 5 min. The resin was first washed with 
DMF (dimethylformamide) (10ml×6 times, 3 min each) and then in DCM (10 ml×3 times, 3 min 
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each). Next, the resin was dried for 12 hours under high vacuum. Yield > 90%. Substitution: 0.59 
mmoles/g.  
The remaining amino acids were coupled automatically by using 5.0 equivalents excess of Fmoc-
amino acids, 5 min at 75 °C, 35 Watt, in presence of PyBOP (benzotriazol-1-yl-
oxytripyrrolidinophosphonium hexafluorophosphate), DIPEA in DMF and the Fmoc-deprotection 
steps (20% piperidine in DMF) were completed within 3 min at 75 °C.  
The cleavage from the resin was pursued with TFA/ TIPS/ EDT (95:3:2, v:v) for 2 h at room 
temperature. The peptide was then precipitated and washed with diethyl ether. The obtained solid 
was dissolved in water with 5% of DMSO (dimethyl sulfoxide) and stirred for 24 h to afford the 
cyclization of the two Cys residues within the peptides. The solution was lyophilized to give the 
final product (166 mg, yield 61%, Purity = 91% for C*NNSKSHTC* and 72 mg, yield 65 %, purity 
92 % for HSC*NKNSC*T). 
Analytical HPLC-MS was carried out on a Waters Fraction Lynx autopurification system equipped 
with micromass ZQ (ESCI ionization mode and dual-λ detectors), column Waters Atlantis RP-C18, 
5 µm, 4.6 mm × 150 mm, eluents A, H2O(0,1 % TFA); B, CH3CN (0,1% TFA), elution initial 
condition 5% B, linear gradient 5-10% B over 2.49 min, 10-15% B over 15 min, flow rate 1 ml/min, 
UV detection at 220 nm. tR= 8.4 min, MS-ESI(+) m/z: 1107[M+H]
+, 554[M+2H]2+, calculated for 
C41H66N14O18S2 =1106. The corresponding data for HSC*NKNSC*T were tR= 9.4 min, MS-ESI(+): 
m/z: found: 1106[M+H]+, 554[M+2H]2+ calculated for C41H66N14O18S2 = 1106. 
Peptides were also characterized by 1H-NMR and 2D-TOCSY, NOESY and COSY spectra in H2O 
(0.550 ml) - D2O (0.050 ml) at pH 5 and room temperature. NMR spectra were recorded on Bruker 
Avance 600 spectrometer and analyzed using the Computed Aided Resonance Assignment software 
(The Swiss Federal Institute of Technology, Zurich, Switzerland) (Figure S1 and Table S1).  
 
 
 
Page 19 of 30
ACS Paragon Plus Environment
Bioconjugate Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
20 
 
Preparation and purification of DSPE-PEG2000-Peptide  
A solution of the cyclic nonapeptide (0.020 g, 0.017 mmol) dissolved in anhydrous DMF (1.0 mL) 
was added to a solution of DSG (41.0 mg, 0.128 mmol) dissolved in anhydrous DMF (0.5 mL) 
containing DIPEA (0.057 mL, 0.34 mmol, 20 equivalent), and the solution was vigorously shaken 
for 2 min. The reaction mixture was stirred for 5 min. Then, 10 mL of ethyl acetate was added to 
the reaction mixture and the precipitate, corresponding to the glutaric acid monoamide mono-NHS 
ester of the peptides, was centrifuged to a pellet and washed twice with ethyl acetate (10 mL). A 
solution of this product in anhydrous DMSO (0.5 mL) containing DIPEA (0.050 mL, 0.3 mmol, 20 
equiv), was added to a DMSO solution (0.5 mL) of DSPE-PEG2000-NH2 (0.021 g, 0.0075 mmol, 
0.5 equiv.), and the mixture was stirred at room temperature. The reaction was monitored by 
analytical HPLC and reached the completeness after 24 h. The reaction mixture was added with 10 
ml of water and then lyophilized. The products were purified by preparative HPLC using Waters 
XTerra RPdC8, 19/100 column, 7 mM CH3COONH4 (A) e CH3CN (B) as eluents, initial condition 
40 % B, 40-80 % B in 2.45 min, 80-90 % B in 7 min, flow rate 20 ml/min. 
Analytical HPLC: tR= 17.55 min., purity 70 %, column Fluofix 120 E (4.6 mm ×250 mm), eluents: 
A, H2O; B, ethanol: isopropyl alcohol 70:30 (v/v), elution, initial condition 20% B, isocratic 
gradient 20% B in 5 min, 20-80 % B in 20 min, 80-100 % B in 3 min, flow rate 1.2 ml/min, column 
temperature 40°C, ELSD detection (temp 45°C, pressure 35 atm). 
C*NNSKSHTC*: MS-MALDI–TOF: m/z: 4017 calcd C178H333N16O74PS2 = 3974. 
HSC*NKNSC*T: MS-MALDI–TOF: m/z: 4005 calcd C178H335N17O74PS2 = 3977. 
MS spectra are reported in Figures S2, S3, and S4. 
 
Mixed micelles preparation 
Micelles were formulated with DSPE-PEG2000-OMe, Gd-DOTAMA(C18)2 and DSPE-PEG2000-
VCAM1-pep (or scr) in a molar ratio of 58:40:2 respectively. The mixture (total amount 22.5 mg) 
was dissolved in chloroform and MeOH (4:1 v/v), and the solution was slowly evaporated (30°C) to 
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form a thin film on the bottom of a flask. The film was hydrated at 50 °C for 10 min adding 1.5 ml 
of HEPES-buffered saline (pH 7.4, 38 mM of HEPES, 0.15 M of NaCl). The suspension was 
sonicated twice for 90 sec (power 70%, Sonicator Bandelin Sonoplus HD 2070, Berlin, Germany). 
During the sonication the mixture was cooled with ice to keep the temperature under 10°C. 
 
Micelle characterization 
The millimolar longitudinal relaxivity (r1) of the paramagnetic nanoparticles was measured at 0.5 T 
(Stelar Spinmaster Spectrometer, Pavia, Italy). The concentration of Gd(III) in the micelles 
suspension was determined by relaxometry.44 The mean hydrodynamic diameter of the particles was 
determined using Dynamic Light Scattering (Malvern ZS Nanosizer, UK) with a scattering angle of 
90°C. The polydispersion index (PDI) was used as indicator of the particle size distribution. Micelle 
stability was investigated monitoring longitudinal relaxivity and size over 5 days (DLS) and 15 
days (relaxometry) in human serum (HS, SERO, Billingstad, Norway). The relaxation rate of the 
micelles-containing suspension was also measured at 25°C over magnetic field strengths ranging 
from 7 to 20 MHz (Spinmaster FFC2000 1T C/DC, Stelar, Mede (PV), Italy). Additional values at 
higher Larmor frequencies (30-70 MHz) were obtained with a tunable relaxometer (Spinmaster, 
tunable magnet, Stelar, Mede (PV), Italy). Temperature was controlled with a Stelar VTC-91 
airflow heater equipped with a calibrated copper−constantan thermocouple (uncertainty of ±0.1 K). 
Variable-temperature 17O NMR measurements were recorded on a Bruker Avance 600 spectrometer 
equipped with a 5 mm probe and standard temperature control unit. The micelle suspension 
contained 2.0% of 17O water (Cambridge Isotope). 
The observed transverse relaxation rates were calculated from the signal width at half-height. 
The paramagnetic contribution was calculated using a suspension of Gd-free micelles. 
The number of Gd(III)-complexes loaded in a single micelle was estimated as follows: 
	
n
micelle
Gd =
n
T
Gd
n
T
micelle
 [1] 
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where nT
Gd and nT
micelle represent the total number of Gd-complexes and particles, respectively. 
nT
micelle can be obtained from the ratio between the total surface area of the micelles (AT) over the 
surface of the single, spherical, particle: 
	
n
T
micelle =
A
T
A
sin gle
=
A
T
Gd + A
T
DSPE
4πr2
=
molGdN
AV
AGd +molDSPEN
AV
ADSPE
4πr2
 [2] 
where moliNAV terms refer to the number of Gd-complexes (i = Gd) and DSPE molecules (i = 
DSPE) in a given micelles suspension, Ai values represent the molecular surface areas for the two 
components, and r is the average particles radius (NAV is the Avogadro’s constant). 
Under the assumption that the molar ratio between the micelle components does not vary during the 
preparation:  
	
molDSPE =molGd
%
DSPE
%
Gd
 [3] 
where %i represents the molar ratio of the i component in the formulation (in this work 40 % and 60 
% for Gd-DOTAMA(C18)2 and DSPE-PEG2000, respectively).  
Eq. 1 can be rearranged considering Eqs. 2-3 and substituting nT
Gd with molGdNAV:  
 
                  [4] 
  
Animal model 
C57BL/6J male mice (20–25 g) were divided into two groups: A) LPS inflamed mice receiving the 
targeted micelles (n=6), and B) LPS inflamed mice receiving the untargeted micelles exposing the 
scrambled peptide (n=6). The inflammation was induced in the right calf muscle by intramuscular 
injection of 100 µl of LPS 0.5 mg/mL in PBS (phosphate buffer saline) (LPS, Escherichia coli 
055:B5) under 1.5% isoflurane anesthesia. In control mice 100 µl PBS were injected in the right 
calf muscle. Animals were recruited for MRI 48 h after LPS injection. The model was validated 
histologically. To this purpose, 48 h post LPS injection, right and left legs were excised and 
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immediately cryopreserved in Optimum Cutting Temperature (O.C.T.) compound (VWR 
International) (5 min in liquid nitrogen before cooling down to -80°C). Slices (thickness 5 µm) were 
cut using a cryostat (Leica CM 1950) and fixed in formalin for 10 min. Sections were then 
hydrated, stained with hematoxylin and eosin and dehydrated to be mounted with a coverslip. 
Images of the samples were obtained by using the Olympus BH2 optical microscope. 
Animal manipulation and experimental procedures were carried out in accordance with the 
European Community guidelines, and under the approval of the Italian Ministry of Health. 
 
Immunofluorescence  
Indirect immunofluorescent detection and localization of VCAM-1 receptors were performed. 
Sections (5-µm thick) of the leg muscles were cut with a cryostat (Leica CM 1950) and then fixed 
with ethanol 99% at room temperature for 8 min and washed with PBS. To block nonspecific 
binding sites, sections were incubated for 1 h with 10% BSA (Bovine Serum Albumin) in PBS. 
Sections were then incubated with primary Ab (ab24853 – Abcam) at 4°C (diluted 1:200 for 
VCAM-1 in PBS containing 10% BSA) overnight. After three washings with PBS, sections were 
incubated for 60 min with FITC-tagged goat anti-rat IgG (35552 - ThermoFisher) (1:500 dilution in 
PBS) at room temperature. After washings with PBS, sections were stained with Hoechst (33342 –
Sigma) (1:10000 dilution in PBS for nuclear staining). After fast (5 min) washing in bidistilled 
water, the sections were mounted with ProLong (ThermoFisher) antifade mountant. Microscopic 
observation and image acquisition were performed with a Leica TCS SP5 confocal microscope 
(Leica Microsystems s.r.l.). 
 
In vivo MRI experiments 
48 h post LPS injection, 200 µL of a suspension of targeted or untargeted micelles (0.055 mmol 
Gd/kg bw) were intravenously administered to C57BL/6J mice. MRI was performed before and 
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then 20 min, 40 min, 4 h, 4.5 h, and 24 h after micelle injection on a Bruker Icon (1 T). A RARE 
sequence with the following acquisition parameters was used: TR/TE = 380/14.7 ms, matrix = 256, 
no. of averages = 6, FOV = 5 cm, slice thickness = 1.5 mm, 121 axial slices, TA = 254 s). Mice 
were kept under isoflurane anaesthesia during the image acquisition.  
 
ICP-MS measurements 
ICP-MS (Thermo Scientific ELEMENT 2 ICP-MS -Finnigan, Rodano, Milano, Italy) was used to 
quantify Gd (III) on explanted tissues. Inflamed and contralateral healthy muscles of mice injected 
with the micelles were resected 4 h post injection. The specimens were digested in nitric acid (1 
mL) and then mineralized at 160°C under microwave heating (Milestone MicroSYNTH Microwave 
labstation equipped with an optical fiber temperature control and HPR-1000/6M six position high-
pressure reactor, Bergamo, Italy).  
  
Image processing and analysis 
Image analysis was performed using Bruker ParaVision 4.0 software. Regions of interest (ROIs) 
were manually drawn over the inflamed and controlateral healthy leg in all the axial imaging slices 
and the average signal intensity was calculated. The % T1 contrast enhancement at a given time 
after administration (%T1
enh
(t)) was obtained as follows: 
 
where SPRE and S(t)
POST
 represent the average signal before and after the injection of the contrast 
agent, respectively.35 p values were calculated using t-Student’s test, assuming statistical 
significance at p < 0.05 and p < 0.01. 
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Abbreviation 
BSA, bovine serum albumin; COSY, correlation spectroscopy; DCM, dichloromethane; DIPEA, 
diisopropylethylamine; DLS, dinamic light scattering;  DMF dimethylformamide; DMSO, dimethyl 
sulfoxide; EDT, ethanedithiol; ELSD, evaporative light scattering detector; FMOC, 
fluorenylmethyloxycarbonyl chloride; H&E, hematoxylin-eosin; HPLC, high performance liquid 
chromatography; ICP-MS, inductively coupled plasma mass spectrometry; LPS, 
lipopolysaccharide; MALDI – TOF, matrix assisted laser desorption ionization – time of flight; 
MeOH, methanol; MS-ESI, mass spectroscopy – electrospray ionization; NOESY, nuclear 
overhauser effect spectroscopy; NMRD, nuclear magnetic relaxation dispersion; PBS, phosphate 
buffer saline; PyBOP, benzotriazol-1-yl oxytripyrrolidinophosphonium hexafluorophosphate; SAP, 
square antiprismatic; SE, standard error; TFA, trifluoroacetic acid;   TIPS, triisopropylsilane; 
TOCSY, total correlation spectroscopy; TSAP, twisted square antiprismatic; VCAM, vascular cell 
adhesion molecule;  
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